MedTrace Logo

Cooled RF Lesion MRI Characteristics

NCT03631030 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-08-07

No results posted yet for this study

Summary

This Prospective, Single-center, Pilot Study will assist in gaining an understanding of the actual CRFA lesions in an in vivo situation in areas where CRFA is utilized as a standard of care treatment option for the relief of chronic pain (cervical facet joints, thoracic facet joints, lumbar facet joints, Sacroiliac (SI) region, hip and knee).

Conditions

  • Arthritis;Lumbosacral
  • Osteo Arthritis Knee
  • Sacroiliitis
  • Hip Osteoarthritis
  • Arthritis, Degenerative

Interventions

DEVICE

Cooled radiofrequency ablation

Cooled Radiofrequency ablation (CRFA) is a well-established method for delivering lesions into nervous tissue to accomplish neurotomy procedures

Sponsors & Collaborators

  • Halyard Health

    collaborator INDUSTRY

  • International Spine, Pain and Performance Center

    lead OTHER

Principal Investigators

  • Mehul Desai, MD, MPH · International Spine Pain & Performance Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-25
Primary Completion
2020-01-31
Completion
2020-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03631030 on ClinicalTrials.gov